Editorial: Advancements in immunology and immunotherapy for breast cancer

Front Oncol. 2022 Aug 9:12:979806. doi: 10.3389/fonc.2022.979806. eCollection 2022.

Authors

Tomoharu Sugie¹, Roberto Salgado^{2

3}, Lawrence Fong⁴

Affiliations

¹ Breast Surgery, Kansai Medical University Hospital, Hirakata, Japan.
² Department of Pathology, GZA-ZNA-Hospitals, Antwerp, Belgium.
³ Division of Research, Peter Mac Callum Cancer Centre, Melbourne, VIC, Australia.
⁴ Division of Hematology/Oncology, University of California, San Francisco, San Francisco, CA, United States.

No abstract available

Keywords: Biomarker; Breast cancer; Immunotherapy; Programmed death ligand (PD-L) 1; Tumor microenvironment.

Publication types

Editorial